Acute Porphyria Drug Database

C10AX09 - Ezetimibe
Propably not porphyrinogenic
PNP

Rationale
Probably non-CYP metabolism. No data pointing to any interaction with the metabolism of CYP-metabolised drugs.
Chemical description
Selective inhibitor of intestinal cholesterol absorbtion. Mainly metabolized in the liver and intestinal wall via glucuroidation (phase II reaction) and eliminated via bile.
IPNet drug reports
Uneventful use reported in 8 patients with acute porphyria.

Similar drugs
Explore alternative drugs in similar therapeutic classes C10A / C10AX or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙